Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

Merck hired Barry Goldstein as vp, diabetes & obesity clinical development;
Merck Serono has hired Robert Fairless to head its UK and Ireland legal activities;
NeuroDiscovery named Chris Moyses as a non-executive board director;
Arno Therapeutics hired Roger Berlin as ceo;
Wyeth hired Dan McIntyre, as vp corporate communications;
AMRI promoted Steve Hagen to vp of pharma development and manufacturing;
AMRI promoted Luckner Ulysse Jr to vp, chemical development;
Cumberland Pharma hired Martin Cearnal as senior vp of commercial development;
Aegerion Pharma says Jerry Wisler, a founder and the ceo, left to pursue personal interests;
RHEI Pharmaceuticals named Geert Cauwenbergh as ceo;
Axial Biotech named Rina Wolf vp of reimbursement and regulatory affairs;
Cadence Pharma appointed Todd Rich to its board;
Cadence Pharma named Mallcolm Lloyd-Smith sr vp, regulatory affairs and quality assurance;